ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

32704 results sorted by trial registration date.
  • Psychosocial Outcomes In Stroke

    An observational stroke cohort study of younger (18-65 years) patients admitted to a stroke units in NSW surviving to 28 days. 440 participants will be enrolled from approximately 20 stroke units over a 12 month recruitment period commencing August 2008. Following admission, and prior to 28 days post stroke, all stroke survivors aged between 18 and 65 years will be invited to be interviewed and data will be collected on demographic information, the stroke event (extracted from hospital records) and psychiatric history. At 28 days, and 6 and 12 months following their stroke data will be collected on psychosocial disability using the World Health Organisation Disability Assessment Schedule (WHO-DAS) and mood from participants during telephone interviews conducted by trained researchers based at The George Institute. The primary objective is to determine if treatable early (within 28 days of stroke) psychosocial factors are associated with return to work (paid and unpaid) at one year. The secondary objective is to determine the economic impact of not returning to work for stroke survivors.

  • A phase 1 clinical trial of peptide-pulsed monocyte-derived dendritic cell vaccination to expand adoptively transferred cytomegalovirus -specific cytotoxic T lymphocytes after allogeneic stem cell transplantation

    A preliminary study of the use of immune cells from transplant donors to prevent cytomegalovirus infection in recipients of blood stem cell transplants. The study hypothesis is that stimulation of infused CMV specific lymphocytes by CMV peptide pulsed DC given as a vaccine will enhance immune reconstitution. The study will use two different sorts of immune cells (called T lymphocytes and dendritic cells). These cells will be prepared in the laboratory and given back to patients after transplant to try to prevent diseases caused by the CMV virus.

  • The efficacy of a novel, non-robotic intervention to train reaching post stroke

    Up to 50% of stroke survivors are left with upper limb disability that limits their daily activities. Several studies have established that recovery of function post stroke is maximised by active, repetitive use of the involved limb in task oriented training programs. Unfortunately for many stroke survivors, the degree of hemiparesis (or paralysis) is so severe that they are unable to generate enough strength to be involved in exercise training. To address this, a low cost, non-robotic training device (The SMART Arm) was developed by the investigators to provide a smooth and guided track to make reaching easier in people with severe weakness. Using the device with and without triggered electrical stimulation has led to improvements in function and strength in chronic stroke survivors. The current study aims to investigate the ability of the SMART arm with and without triggered stimulation to improve arm impairment, activity and participation in acute stroke survivors.

  • A double blind randomised placebo controlled study using clarithromycin in the treatment of children with bronchiolitis

    to see whether clarithromycin improves the clinical course of bronchiolitis requiring admission to hospital.

  • A clinical study to determine the safety and efficacy of gadobutrol 1.0 molar (Gadovist 'Registered trade mark') in comparison to ProHance 'Registered trade mark' (gadoteridol) 0.5 molar in patients referred for contrast-enhanced Magnetic Resonance Imaging (MRI) of the central nervous system.

    This study involves the use of Magnetic Resonance Imaging (MRI) contrast agents called gadobutrol (Gadovist®) Injection and ProHance® Injection. The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of gadobutrol when used for taking MR images of the brain and spine. The results of the MRI with gadobutrol Injection will be compared to the results of MR images taken without contrast and with the results of the MR images taken with ProHance®.

  • A randomised control trial of treatments for children with different types of reading difficulty

    This study tested potential treatments for Australian children who have severe problems learning to read. Some of poor readers find it hard to read via the letter-sound rules (phonics), some find it hard to read whole words by sight (sight-word reading), and many have both of these problems. In this study, one group of poor readers (N = 36) did 8 weeks of phonics training and then 8 weeks of sight word training; one group did the reverse (N = 36); and one group did phonics and sight word training simultaneously for two 8-week periods (N = 32). Sight word training lead to significant gains in sight word reading measures that were larger than gains made from phonics training; phonics training lead to statistically significant gains in a phonics reading measure that were larger than gains made from sight word training; and both types of training lead to significant gains in general reading that were similar in size. Training phonics before sight words had a slight advantage over the reverse order. These findings demonstrate the reliability of both phonics and sight word training in treating poor readers. This will aid Australia’s efforts to counteract the effects of poor reading in children by revealing how different treatments should be tailored to children with different types of reading impairment.

  • Dietary fat and the management of overweight

    This study aimed to demonstrate that a low fat diet with a higher proportion of polyunsaturated fat will be more beneficial than standard low fat diets for overweight individuals

  • Use of glycaemic index knowledge to improve postprandial glycaemia in paediatric patients on insulin pump therapy - what proportion of the meal needs to be low glycaemic index for benefit to glycaemic outcome

    It is hypothesised that consideration of glycaemic index (GI) knowledge and the deliberate use of GI foods to modify low/high GI meals will improve post-prandial glycaemia in patients on insulin pump therapy. Aims: To investigate the effectiveness of clinical dietary advice regarding use of GI knowledge to improve PPG in pediatric patients with T1DM on insulin pump therapy; 1. To assess the clinical effectiveness of the dietary advice regarding the addition of a low GI food to a high GI meal to determine what proportion of the meal needs to contain low GI carbohydrates to improve postprandial glycaemic outcome.

  • Safety and Feasibility of a Load Bypass Knee Support System (LBKSS) for the Treatment of Osteoarthritis

    This study is a multi-center, prospective, open label, feasibility study enrolling up to 30 patients. Safety and feasibility are the primary objectives based on completion of surgical implantation and analysis of reported and observed adverse events. A series of validated subject-completed questionnaires, a visual analogue scale for pain and formal orthopaedic examination, will be performed over the course of the 60 months at the following intervals: baseline, 24-48 hours post-op, 2 weeks, 6 weeks, 3 months, 6, 12, 24, 36, 48 and 60 months. X-ray and/or MRI data will be collected pre-operatively and the following post operative intervals, 2 weeks, 6 months, 12 months, 24 months and 60 months.

  • Impact of iron on insulin resistance in people with hepatitis associated with non-alcoholic fatty liver disease.

    Fat and inflammation in the liver caused by insulin resistance and oxidative stress is termed nonalcoholic steatohepatitis (NASH). NASH is the commonest cause of hepatitis in Australia and may lead to cirrhosis, liver cancer and death. Current therapies are largely ineffective. Iron in the body has been linked to promoting insulin resistance and oxidative stress and thus represents a suitable treatment target. This proposal examines the effect of removing iron by venesection in patients with NASH compared to controls. The effect on insulin resistance, oxidative stress and liver fat, inflammation and scarring will be assessed during the trial.

Tags:
  • Finding clinical trials